<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-23T23:03:26Z</responseDate><request verb="GetRecord" identifier="oai:www.repository.cam.ac.uk:1810/372321" metadataPrefix="uketd_dc">https://api.repository.cam.ac.uk/server/oai/request</request><GetRecord><record><header><identifier>oai:www.repository.cam.ac.uk:1810/372321</identifier><datestamp>2024-09-04T17:12:59Z</datestamp><setSpec>com_1810_263977</setSpec><setSpec>com_1810_221767</setSpec><setSpec>com_1810_256067</setSpec><setSpec>col_1810_263989</setSpec></header><metadata><uketd_dc:uketddc xmlns:uketd_dc="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:uketdterms="http://naca.central.cranfield.ac.uk/ethos-oai/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/ http://naca.central.cranfield.ac.uk/ethos-oai/2.0/uketd_dc.xsd">
   <dc:title>Investigating the translational and metabolic reprogramming of the bone marrow niche in myeloid malignancy</dc:title>
   <dc:identifier xsi:type="dcterms:DOI">https://doi.org/10.17863/CAM.111189</dc:identifier>
   <dc:creator>Lisi-Vega, Livia E</dc:creator>
   <uketdterms:advisor>Méndez-Ferrer, Simón</uketdterms:advisor>
   <dcterms:abstract>In acute myeloid leukaemia (AML), malignant cells surviving chemotherapy rely on high
mRNA translation and their microenvironmental metabolic support to drive relapse. However,
the role of translational reprogramming in the niche was, until now, unclear. This study found
that relapsing AML cells increase translation in their bone marrow (BM) niches, where BM
mesenchymal stromal cells (BMSCs) become a source of eIF4A-cap-dependent translation
machinery that is transferred to AML cells via extracellular vesicles (EVs), to meet their
translational demands. In two independent models of highly chemo-resistant AML driven by
MLL-AF9 or FLT3-ITD;NPMc mutations, we show that AML protein synthesis levels increase
at relapse dependently on nestin+ BMSCs. Inhibiting cap-dependent translation in BMSCs
abolishes their chemoprotective ability, whereas BMSCs and their EVs rescue cap-dependent
translation inhibition and survival of AML cells. Consequently, eIF4A inhibition synergises
with conventional chemotherapy and treatment with BMSC-derived EVs increases AML
translation and accelerates disease progression after therapy. Together, these results suggest
that AML cells rely on BMSCs to maintain an oncogenic translational program required for
relapse.</dcterms:abstract>
   <uketdterms:institution>University of Cambridge</uketdterms:institution>
   <dcterms:issued>2024-04-10</dcterms:issued>
   <dc:type>Thesis</dc:type>
   <uketdterms:qualificationlevel>Doctoral</uketdterms:qualificationlevel>
   <uketdterms:qualificationname>Doctor of Philosophy (PhD)</uketdterms:qualificationname>
   <dc:language>eng</dc:language>
   <dcterms:isReferencedBy xsi:type="dcterms:URI">https://www.repository.cam.ac.uk/handle/1810/372321</dcterms:isReferencedBy>
   <uketdterms:embargotype>embargo</uketdterms:embargotype>
   <uketdterms:embargodate>2025-09-03</uketdterms:embargodate>
   <dc:identifier xsi:type="dcterms:URI">https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/3b5544d1-de89-410f-abbe-2facce25c0e1/download</dc:identifier>
   <uketdterms:checksum xsi:type="uketdterms:MD5">7dc740439ece8c7e9decea6013fe2580</uketdterms:checksum>
   <dcterms:license>https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/226b9eb7-8e76-4785-becd-0fc03aa3226c/download</dcterms:license>
   <uketdterms:checksum xsi:type="uketdterms:MD5">87eda9de84448d1f82354d60eee3eb5f</uketdterms:checksum>
   <dc:rights>https://www.rioxx.net/licenses/all-rights-reserved/</dc:rights>
   <dc:subject>AML</dc:subject>
   <dc:subject>BMSCs</dc:subject>
   <dc:subject>bone marrow</dc:subject>
   <dc:subject>bone marrow mesenchymal stem cells</dc:subject>
   <dc:subject>chemoresistance</dc:subject>
   <dc:subject>metabolism</dc:subject>
   <dc:subject>niche</dc:subject>
   <dc:subject>translation</dc:subject>
</uketd_dc:uketddc>
</metadata></record></GetRecord></OAI-PMH>